The tumour-associated carbonic anhydrases CA II, CA IX and CA XII in a group of medulloblastomas and supratentorial primitive neuroectodermal tumours: an association of CA IX with poor prognosis

被引：0
|
作者：
Kristiina Nordfors
Joonas Haapasalo
Miikka Korja
Anssi Niemelä
Jukka Laine
Anna-Kaisa Parkkila
Silvia Pastorekova
Jaromir Pastorek
Abdul Waheed
William S Sly
Seppo Parkkila
Hannu Haapasalo
机构：
[1] Tampere University Hospital,Department of Pathology
[2] Helsinki University Central Hospital,Department of Neurosurgery
[3] University of Turku,Department of Medical Biochemistry and Genetics
[4] Turku University Hospital,Department of Pathology
[5] Tampere University Hospital,Department of Neurology
[6] Slovak Academy of Sciences,Centre of Molecular Medicine, Institute of Virology
[7] Saint Louis University School of Medicine,Edward A. Doisy Department of Biochemistry and Molecular Biology
[8] University of Tampere and Tampere University Hospital,Institute of Medical Technology and School of Medicine
来源：
BMC Cancer | / 10卷
关键词：
Acute Myeloid Leukemia; Medulloblastoma; Astrocytic Tumour; Diffuse Astrocytoma; Supratentorial Primitive Neuroectodermal Tumour;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Carbonic anhydrase inhibitors: inhibition of the tumor-associated isozyme IX with fluorine-containing sulfonamides. The first subnanomolar CA IX inhibitor discovered
    Vullo, D
    Scozzafava, A
    Pastorekova, S
    Pastorek, J
    Supuran, CT
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (09) : 2351 - 2356
  • [32] CA IX is an independent predictor of poor prognosis in breast carcinoma: Results from a population based study of 4150 breast cancers
    Clarke, BA
    Cheang, MC
    Rajput, A
    Chia, SK
    Gilks, CB
    Huntsman, DG
    MODERN PATHOLOGY, 2006, 19 : 24A - 24A
  • [33] CA IX is an independent predictor of poor prognosis in breast carcinoma: Results from a population based study of 4150 breast cancers
    Clarke, BA
    Cheang, MC
    Rajput, A
    Chia, SK
    Gilks, CB
    Huntsman, DG
    LABORATORY INVESTIGATION, 2006, 86 : 24A - 24A
  • [34] Expression of CA-IX is associated with advanced stage tumors and poor survival in oral squamous cell carcinoma patients
    Perez-Sayans, Mario
    Manuel Suarez-Penaranda, Jose
    Pilar, Gayoso-Diz
    Supuran, Claudiu T.
    Pastorekova, Silvia
    Barros-Angueira, Francisco
    Manuel Gandara-Rey, Jose
    Garcia-Garcia, Abel
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2012, 41 (09) : 667 - 674
  • [35] Low CA II expression is associated with tumor aggressiveness and poor prognosis in gastric cancer patients
    Hu, Xiaotong
    Huang, Zhongting
    Liao, Zhongcai
    He, Chao
    Fang, Xiao
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (10): : 6716 - 6724
  • [36] Carbonic anhydrase IX (CA IX) is an independent poor prognostic factor in early stage breast cancer: results from a large population-based tissue microarray (TMA) series.
    Chia, S
    Cheang, M
    Yorida, E
    Makretsov, N
    Turbin, D
    Massoudi, H
    Hayes, M
    Gelmon, K
    Olivotto, I
    Speers, C
    Harris, A
    Huntsman, D
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S116 - S117
  • [37] Expression of carbonic anhydrase IX (CA IX), a hypoxia-related protein, rather than vascular-endothelial growth factor (VEGF), a pro-angiogenic factor, correlates with an extremely poor prognosis in esophageal and gastric adenocarcinomas
    Driessen, A
    Landuyt, W
    Pastorekova, S
    Moons, J
    Goethals, L
    Haustermans, K
    Nafteux, P
    Penninckx, F
    Geboes, K
    Lerut, T
    Ectors, N
    ANNALS OF SURGERY, 2006, 243 (03) : 334 - 340
  • [38] Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: Correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix
    Loncaster, JA
    Harris, AL
    Davidson, SE
    Logue, JP
    Hunter, RD
    Wycoff, CC
    Pastorek, J
    Ratcliffe, PJ
    Stratford, IJ
    West, CML
    CANCER RESEARCH, 2001, 61 (17) : 6394 - 6399
  • [39] Indanesulfonamides as carbonic anhydrase inhibitors. Toward structure-based design of selective inhibitors of the tumor-associated isozyme CA IX
    Thiry, A
    Ledecq, M
    Cecchi, A
    Dogne, JM
    Wouters, J
    Supuran, CT
    Masereel, B
    JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (09) : 2743 - 2749
  • [40] Transcriptional regulation of the MN/CA 9 gene coding for the tumor-associated carbonic anhydrase IX: Identification and characterization of a proximal silencer element
    Kaluz, Stefan
    Kaluzova, Milota
    Opavsky, Rene
    Pastorekova, Silvia
    Gibadulinova, Adriana
    Dequiedt, Franck
    Kettmann, Richard
    Pastorek, Jaromir
    Journal of Biological Chemistry, 274 (46): : 32588 - 32595
12345